326 related articles for article (PubMed ID: 26268815)
21. Study on association of human leukocyte antigen-DRB1 alleles amongst Bangladeshi patients with rheumatoid arthritis.
Begum M; Sattar H; Haq SA; Islam MN; Saha SK; Hassan MM; Saha R; Kabir MS
Int J Rheum Dis; 2018 Aug; 21(8):1543-1547. PubMed ID: 29624881
[TBL] [Abstract][Full Text] [Related]
22. Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis.
Mattey DL; Dawes PT; Clarke S; Fisher J; Brownfield A; Thomson W; Hajeer AH; Ollier WE
Arthritis Rheum; 2002 Aug; 47(4):403-7. PubMed ID: 12209487
[TBL] [Abstract][Full Text] [Related]
23. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
24. HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles.
Nordang GB; Flåm ST; Maehlen MT; Kvien TK; Viken MK; Lie BA
Rheumatology (Oxford); 2013 Nov; 52(11):1973-82. PubMed ID: 23901134
[TBL] [Abstract][Full Text] [Related]
25. Secukinumab Improves Physical Function in Subjects With Plaque Psoriasis and Psoriatic Arthritis: Results from Two Randomized, Phase 3 Trials.
Gottlieb AB; Langley RG; Philipp S; Sigurgeirsson B; Blauvelt A; Martin R; Papavassilis C; Mpofu S
J Drugs Dermatol; 2015 Aug; 14(8):821-33. PubMed ID: 26267726
[TBL] [Abstract][Full Text] [Related]
26. The role of HLA-DRB1 shared epitope alleles in predicting short-term response to leflunomide in rheumatoid arthritis.
Saruhan-Direskeneli G; Inanc M; Fresko I; Akkoc N; Dalkilic E; Erken E; Karaaslan Y; Kinikli G; Oksel F; Pay S; Yucel E; Yentür SP; Duymaz-Tozkir J; Yilmaz V; Inanc N; Yazici H; Konice M; Direskeneli H
Rheumatology (Oxford); 2007 Dec; 46(12):1842-4. PubMed ID: 18032542
[TBL] [Abstract][Full Text] [Related]
27. Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.
Okada Y; Yamada R; Suzuki A; Kochi Y; Shimane K; Myouzen K; Kubo M; Nakamura Y; Yamamoto K
Arthritis Rheum; 2009 Dec; 60(12):3582-90. PubMed ID: 19950296
[TBL] [Abstract][Full Text] [Related]
28. Association of polymorphisms of HLA-DRB1 and TNF-308 G/A with radiographic joint damage in patients with early rheumatoid arthritis with high inflammatory activity, treated according to the principle of "Treat to target" (REMARKA study).
Guseva IA; Smirnov AV; Demidova NV; Krylov MY; Avdeeva AS; Samarkina EY; Luchikhina EL; Karateev DE; Abramov DD; Nasonov EL
Ter Arkh; 2018 May; 90(5):38-43. PubMed ID: 30701887
[TBL] [Abstract][Full Text] [Related]
29. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.
van der Helm-van Mil AH; Verpoort KN; Breedveld FC; Huizinga TW; Toes RE; de Vries RR
Arthritis Rheum; 2006 Apr; 54(4):1117-21. PubMed ID: 16572446
[TBL] [Abstract][Full Text] [Related]
30. Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3.
Pavelka K; Kivitz A; Dokoupilova E; Blanco R; Maradiaga M; Tahir H; Pricop L; Andersson M; Readie A; Porter B
Arthritis Res Ther; 2017 Dec; 19(1):285. PubMed ID: 29273067
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of elderly-onset rheumatoid arthritis and young-onset rheumatoid arthritis in a Colombian population: clinical, laboratory and HLA-DRB1 findings.
Spinel-Bejarano N; Quintana G; Heredia R; Yunis JJ; Caminos JE; Garcés MF; Rondon F; Iglesias-Gamarra A
Clin Exp Rheumatol; 2013; 31(1):40-6. PubMed ID: 22935200
[TBL] [Abstract][Full Text] [Related]
32. Circulating IFN-γ producing CD4+ T cells and IL-17A producing CD4+ T cells, HLA-shared epitope and ACPA may characterize the clinical response to therapy in rheumatoid arthritis patients.
Alvandpur N; Tabatabaei R; Tahamoli-Roudsari A; Basiri Z; Behzad M; Rezaeepoor M; Roshanaei G; Hajilooi M; Solgi G
Hum Immunol; 2020 May; 81(5):228-236. PubMed ID: 32107036
[TBL] [Abstract][Full Text] [Related]
33. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis.
Michou L; Teixeira VH; Pierlot C; Lasbleiz S; Bardin T; Dieudé P; Prum B; Cornélis F; Petit-Teixeira E
Ann Rheum Dis; 2008 Apr; 67(4):466-70. PubMed ID: 17660221
[TBL] [Abstract][Full Text] [Related]
34. Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis.
Huizinga TW; Batalov A; Stoilov R; Lloyd E; Wagner T; Saurigny D; Souberbielle B; Esfandiari E
Arthritis Res Ther; 2017 Mar; 19(1):53. PubMed ID: 28274253
[TBL] [Abstract][Full Text] [Related]
35. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
36. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.
Linn-Rasker SP; van der Helm-van Mil AH; van Gaalen FA; Kloppenburg M; de Vries RR; le Cessie S; Breedveld FC; Toes RE; Huizinga TW
Ann Rheum Dis; 2006 Mar; 65(3):366-71. PubMed ID: 16014670
[TBL] [Abstract][Full Text] [Related]
37. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
McInnes IB; Mease PJ; Kirkham B; Kavanaugh A; Ritchlin CT; Rahman P; van der Heijde D; Landewé R; Conaghan PG; Gottlieb AB; Richards H; Pricop L; Ligozio G; Patekar M; Mpofu S;
Lancet; 2015 Sep; 386(9999):1137-46. PubMed ID: 26135703
[TBL] [Abstract][Full Text] [Related]
38. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
Huizinga TW; Amos CI; van der Helm-van Mil AH; Chen W; van Gaalen FA; Jawaheer D; Schreuder GM; Wener M; Breedveld FC; Ahmad N; Lum RF; de Vries RR; Gregersen PK; Toes RE; Criswell LA
Arthritis Rheum; 2005 Nov; 52(11):3433-8. PubMed ID: 16255021
[TBL] [Abstract][Full Text] [Related]
39. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
40. Redefining the HLA and RA association: to be or not to be anti-CCP positive.
de Vries RR; Huizinga TW; Toes RE
J Autoimmun; 2005; 25 Suppl():21-5. PubMed ID: 16257178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
